PMA device
Attain Ability Straight Left Ventricular Lead
Medtronic, Inc. · Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode (OJX, Class III) · First FDA decision Mar 31, 2011, newest Feb 9, 2021Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Attain Ability Straight"
MAUDE reports
674
Brand "Attain Ability Straight", since 2015
PubMed studies
0
Mentioning "Attain Ability Straight"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Attain Ability Straight Left Ventricular Lead
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Attain Ability Straight Left Ventricular LeadPMA supplement
P080006-S156 · Decided Feb 9, 2021 · 54 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug eluting permanent left ventricular (lv) pacemaker electrode (OJX) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac PacemakersNational analysisReview closedCAG-00063R3Updated Sep 17, 2026
- Single Chamber and Dual Chamber Permanent Cardiac PacemakersNational determinationOn the books20.8.3Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Attain Ability Straight", any status and sponsor, newest update first.
No registered device study names "Attain Ability Straight".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Attain Ability Straight", and for the whole product code for context.
This brand
674 reports: 341 malfunction, 324 injury, 9 death
Whole product code OJX
40,615 reports: 16,946 malfunction, 22,305 injury, 1,330 death
Newest reports for this brand
- Attain Ability Straight MRI SureScanMalfunction
Medtronic Puerto Rico Villalba
2649622-2026-31733 · Received Oct 26, 2026 · Event dated Jul 3, 2026
Device type: Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode (OJX)
Device problem as coded: Unstable Capture Threshold
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Attain Ability Straight"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OJX.
- Medtronic Attain Ability Model 4196 LeadMedtronic, Inc. · PMA 2020
- Attain StarFix Model 4195 LeadMedtronic, Inc. · PMA 2018
- Consulta Crt-P, Syncra CRT-PMedtronic, Inc. · PMA 2013
- Medtronic Attain Ability Plus Left Ventricular LeadMedtronic, Inc. · PMA 2019
- Attain Performa Model 4398 and 4598 Left Ventricular LeadsMedtronic, Inc. · PMA 2014
- Insync Crt-P/Insync III CRT-PMedtronic, Inc. · PMA 2011
- Attain Stability Quad MRI SureScan LeadMedtronic, Inc. · PMA 2019
- Acuity Spiral LeadsBoston Scientific Corp · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.